title: Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
abstract: OBJECTIVE
  To examine the validity of the Childhood Health Assessment Questionnaire (CHAQ) in patients with juvenile idiopathic inflammatory myopathy (IIM).
  
  
  METHODS
  One hundred fifteen patients were enrolled in a multicenter collaborative study, during which subjects were assessed twice, 7-9 months apart. Physical function was measured using the CHAQ. Internal reliability was assessed using adjusted item-total correlations and item endorsement rates. Construct validity was assessed by comparing predicted and actual correlations of the CHAQ with other measures of physical function and disease activity. Responsiveness was assessed by calculating effect size (ES) and standardized response mean (SRM) in a group of a priori defined "improvers."
  
  
  RESULTS
  Item-total correlations were high (rs range = 0.35-0.81), suggesting all items were related to overall physical function. Manual muscle testing and the Childhood Myositis Assessment Scale correlated moderate to strongly with the CHAQ (r = -0.64 and -0.75, both p < 0.001). Moderate correlations were also seen with the physician global assessment of disease activity (rs = 0.58, p < 0.001), parent global assessment of overall health (rs = -0.65, p < 0.001), Steinbrocker function class (rs = 0.69, p < 0.001), and global skin activity (rs = 0.40, p < 0.001), while global disease damage and skin damage had low correlations (rs = 0.13 and 0.07, p > or =0.17). Responsiveness of the CHAQ was high, with ES = 1.05 and SRM = 1.20.
  
  
  CONCLUSIONS
  In this large cohort of patients with juvenile IIM, the CHAQ exhibited internal reliability, construct validity, and strong responsiveness. We conclude that the CHAQ is a valid measure of physical function in juvenile IIM, appropriate for use in therapeutic trials, and potentially in the clinical care of these patients.
authors.affiliation: Department of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada.
authors.forename: A M
authors.initials: AM
authors.lastname: Huber
authors.forename: J E
authors.initials: JE
authors.lastname: Hicks
authors.forename: P A
authors.initials: PA
authors.lastname: Lachenbruch
authors.forename: M D
authors.initials: MD
authors.lastname: Perez
authors.forename: L S
authors.initials: LS
authors.lastname: Zemel
authors.forename: R M
authors.initials: RM
authors.lastname: Rennebohm
authors.forename: C A
authors.initials: CA
authors.lastname: Wallace
authors.forename: C B
authors.initials: CB
authors.lastname: Lindsley
authors.forename: M H
authors.initials: MH
authors.lastname: Passo
authors.forename: S H
authors.initials: SH
authors.lastname: Ballinger
authors.forename: S L
authors.initials: SL
authors.lastname: Bowyer
authors.forename: A M
authors.initials: AM
authors.lastname: Reed
authors.forename: P H
authors.initials: PH
authors.lastname: White
authors.forename: I M
authors.initials: IM
authors.lastname: Katona
authors.forename: F W
authors.initials: FW
authors.lastname: Miller
authors.forename: L G
authors.initials: LG
authors.lastname: Rider
authors.forename: B M
authors.initials: BM
authors.lastname: Feldman
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003882:Dermatomyositis / Q000175:diagnosis* / Q000628:therapy; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D008297:Male; D017285:Polymyositis / Q000175:diagnosis* / Q000628:therapy; D015203:Reproducibility of Results; D011795:Surveys and Questionnaires / Q000592:standards*; D016896:Treatment Outcome